Regent Pacific Group Limited (HKG:0575)

Market Cap	274.31M +14.4%
Revenue (ttm)	2.83M -49.5%
Net Income	-36.66M
EPS	-0.14
Shares Out	291.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Open	0.9400
Previous Close	0.9400
Day's Range	0.9200 - 0.9400
52-Week Range	0.5700 - 1.2200
Beta	1.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 16
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0575

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 13, 2026

Data Sources Report a data error